Pharmaceutical intermediates
Oliceridine Intermediates
1 pharmaceutical intermediate for Oliceridine. Indication: Acute pain.
About Oliceridine
- Originator
- Trevena Inc
- Indication
- Acute pain
- Approved Date
- 10/30/2020
- NCE Patent
- 10/30/2025
- DS/DP
- 03/23/2032
Available intermediates
1 intermediate currently listed for Oliceridine. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 3-Methoxythiophene-2-carbaldehyde | 35134-07-7 | / | / |
Other programs under O
Building toward Oliceridine?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →